You are here

  • Home
  • Archive
  • Volume 47, Issue 2
  • Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.

Citation Tools

Article menu
Download PDFPDF
Research Article
Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hørslev-Petersen K, Bentsen KD, Engström-Laurent A, et al
Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.
Annals of the Rheumatic Diseases 1988;47:116-126.